Fresenius SE KGaAXSWX:FRE 72 3-Year EPS without NRI Growth Rate is -7.00% as of Mar. 2026. GuruFocus rates XSWX:FRE with a GF Score™ of 72/100 and a GF Value™ of CHF33.76. The stock has 5 warning signs investors should review. Among 512 Healthcare Providers & Services companies, Fresenius SE KGaA ranks worse than 73.44% on this metric.
During the past 12 months, Fresenius SE KGaA's average EPS without NRI Growth Rate was 15.80% per year.
During the past 3 years, the average EPS without NRI Growth Rate was -7.00% per year.
During the past 5 years, the average EPS without NRI Growth Rate was -4.00% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 0.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Fresenius SE KGaA was 38.30% per year. The lowest was -18.60% per year. And the median was 5.70% per year.
Fresenius SE KGaA (XSWX:FRE) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Fresenius SE KGaA 3-Year EPS without NRI Growth Rate Related Terms
XSWX:FRE vs HCA, THC, DVA: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Care Facilities subindustry, Fresenius SE KGaA's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA 3-Year EPS without NRI Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's 3-Year EPS without NRI Growth Rate falls into.
Fresenius SE KGaA 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of -7.00% mean?
Fresenius SE KGaA (XSWX:FRE) has a 3-Year EPS without NRI Growth Rate of -7.00% as of Mar. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Fresenius SE KGaA and its competitors. According to the industry distribution chart, Fresenius SE KGaA ranks #376 out of 512 companies in the Healthcare Providers & Services industry, placing it in the top 73.4%.
Is Fresenius SE KGaA's 3-Year EPS without NRI Growth Rate too high?
Fresenius SE KGaA's current 3-Year EPS without NRI Growth Rate is -7.00%. Based on the distribution chart, Fresenius SE KGaA ranks #376 out of 512 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Fresenius SE KGaA has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's 3-Year EPS without NRI Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #376 out of 512 companies for 3-Year EPS without NRI Growth Rate. This places Fresenius SE KGaA in the lower half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 11.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EPS without NRI Growth Rate among Healthcare Providers & Services companies is 11.65, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Fresenius SE KGaA and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EPS without NRI Growth Rate is 11.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current 3-Year EPS without NRI Growth Rate is -7.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Fresenius SE KGaA (XSWX:FRE) has a current 3-Year EPS without NRI Growth Rate of -7.00%. The stock's GF Value™ is CHF33.76, compared to a current price of CHF39.27 — trading 16.3% above its estimated fair value. The current 3-Year EPS without NRI Growth Rate is -7.00%. Fresenius SE KGaA's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current 3-Year EPS without NRI Growth Rate is -7.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of CHF39.27 is trading 16.3% above its estimated GF Value™ of CHF33.76.
Key valuation signals for XSWX:FRE:
3-Year EPS without NRI Growth Rate: -7.00%
GF Value™: CHF33.76 vs. price of CHF39.27 (16.3% above fair value)
No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
72GF Score
Get the complete analysis for XSWX:FRE
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FRE has been successfully added to your 